Blueprint Medicines Corpo...

NASDAQ: BPMC · Real-Time Price · USD
129.46
0.18 (0.14%)
At close: Jul 17, 2025, 3:59 PM

Blueprint Medicines Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
149.41M 146.37M 128.18M 138.16M 96.12M 71.96M 56.57M 57.57M 63.29M 38.78M 65.98M 36.55M 62.73M 107.02M 24.19M 27.3M 21.58M
Cost of Revenue
2.8M 7.45M 1.93M 11.21M 8M 1.79M 4.55M 2.32M 3.17M 4.85M 3M 4.89M 5.08M 7.55M 3.79M 6.49M 102K
Gross Profit
146.61M 138.92M 126.25M 126.95M 88.11M 70.17M 52.01M 55.25M 60.11M 33.93M 62.98M 31.66M 57.65M 99.47M 20.4M 20.8M 21.47M
Operating Income
-41.09M -41.2M -48.97M -43.05M -78.82M -105.11M -128.98M -127.98M -135.38M -156.81M -124.28M -157.64M -105.8M -316.05M -117.1M -108.51M -100.24M
Interest Income
n/a 10.39M 11.15M 9.94M 9.18M 9.83M 9.33M 7.75M 5.9M n/a 2.95M 433K 442K 1.65M n/a 633K 738K
Pretax Income
1.28M -49.28M -56M -49.89M 89.32M -110.86M -133.52M -132.6M -129.04M -157.6M -132.28M -156.58M -105.81M -316.05M -117.07M -108.25M -99.71M
Net Income
496K -49.96M -56.28M -49.99M 89.14M -110.92M -133.71M -132.79M -129.56M -158.64M -133.16M -159.71M -106M -318.69M -117.24M -108.44M -99.71M
Selling & General & Admin
95.81M 96.45M 89.93M 89.34M 83.56M 79.27M 70.74M 71.93M 70.95M 64.02M 57.61M 58.69M 57.06M 54.2M 49.81M 49.29M 42M
Research & Development
91.89M 83.67M 85.3M 80.65M 83.38M 96.01M 110.25M 110.06M 112.07M 117.84M 127.98M 128.47M 103.13M 356.88M 84.42M 80.03M 79.71M
Other Expenses
n/a n/a n/a -1K 376K -577K -728K n/a 1.3M 1.87M 1.67M 2.15M 3.27M -381K -522K -373K -214K
Operating Expenses
187.7M 180.12M 175.23M 169.99M 166.94M 175.28M 180.99M 183.23M 184.32M 183.73M 187.25M 189.3M 163.46M 415.61M 137.49M 129.31M 121.71M
Interest Expense
-8.13M 18.17M 18.77M 16.8M 15.07M 15M 13.14M 11.74M 11.72M 24.29M 11.35M 6K n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a 30.23M 26.74M 22.71M 16.93M 16.9M 13.07M 18.72M 10.05M 18.1M 7.72M n/a n/a 13.5M n/a n/a n/a
Cost & Expenses
190.5M 187.57M 177.16M 181.2M 174.94M 177.07M 185.55M 185.55M 187.49M 188.58M 190.25M 194.19M 168.53M 423.16M 141.28M 135.81M 121.81M
Income Tax Expense
789K 672K 273K 102K 180K 61K 197K 190K 520K 1.04M 886K 3.13M 184K 2.63M 175K 193K -738K
Shares Outstanding (Basic)
63.6M 63.6M 63.38M 62.85M 61.58M 60.89M 60.69M 60.52M 60.13M 59.87M 59.71M 59.62M 59.31M 58.98M 58.62M 58.41M 58.02M
Shares Outstanding (Diluted)
63.6M 63.6M 63.38M 62.85M 63.8M 60.89M 60.69M 60.52M 60.13M 59.87M 59.76M 59.62M 59.31M 58.98M 58.65M 58.41M 58.02M
EPS (Basic)
0.01 -0.79 -0.89 -0.8 1.45 -1.82 -2.2 -2.19 -2.15 -2.65 -2.23 -2.68 -1.79 -5.4 -2 -1.86 -1.72
EPS (Diluted)
0.01 -0.79 -0.89 -0.8 1.40 -1.82 -2.2 -2.19 -2.15 -2.65 -2.23 -2.68 -1.79 -5.4 -2 -1.86 -1.72
EBITDA
-41.09M -27.11M -33.37M -29.48M -74.01M -103.58M -115.2M -115.03M -111.44M -139.19M -120.16M -155.1M -102.15M -312.75M -113.86M -106.92M -98.63M
EBIT
-6.84M -31.12M -37.24M -33.09M 104.39M -123.46M -120.38M -120.86M -117.32M -147.93M -123.88M -156.57M -105.81M -311.6M -117.07M -108.51M -100.24M
Depreciation & Amortization
-34.24M 4M 3.86M 3.62M 4.81M 1.53M 5.17M 5.83M 5.89M 9.17M 3.73M 3.54M 3.67M 3.3M 3.21M 3.14M 3.13M